(Medical Xpress) -- While stimulants may improve unengaged workers’ performance, a new University of British Columbia study suggests that for others, caffeine and amphetamines can have the opposite effect, causing workers ...
Mar 28, 2012
5
0
New discoveries by researchers at the University of Wisconsin-Milwaukee (UWM) offer potential for development of a first-ever pharmacological treatment for cocaine addiction.
Jul 15, 2011
0
0
Marijuana administered in a timely fashion could block the development of post-traumatic stress disorder symptoms in rats, a new study conducted at Haifa University has found.
Sep 20, 2011
1
0
(Medical Xpress)—Researchers at the Aptuit Centre for Drug Discovery and Development in Italy, have found that a drug called GSK598809 is able to block a type of dopamine receptor in the brain that has been linked to nicotine ...
A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. "Through a glass darkly: can we improve clarity about mechanism and ...
Feb 3, 2012
0
0
Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana (cannabis). Unlike ...
Apr 24, 2012
2
0
Marijuana provides greater pain relief when taken in pill form than when it is smoked, according to a study published on Monday that touches on a controversial medical issue.
Apr 22, 2013
2
14
(Medical Xpress)—Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own lives.
Dec 14, 2012
1
0
(Medical Xpress) -- New UCLA psychology research indicates that Asians who are struggling with alcoholism may benefit especially from naltrexone, one of three medications approved by the U.S. Food and Drug Administration ...
Sep 27, 2011
0
0
Are you good at coping when life gets tough? Do people call you a straight-shooter? Will you help others without expecting anything in return?
Nov 15, 2012
0
0
Neuropsychopharmacology (from Greek νεῦρον, neuron, "nerve"; ψυχή, psyche, "mind", "soul"; φάρμακον, pharmakon, "poison in classic Greek; drug in modern Greek" and the suffix -λογία, -logia, "study of") is an interdisciplinary science related to psychopharmacology (how drugs affect the mind) and fundamental neuroscience. It entails research of mechanisms of neuropathology, pharmacodynamics (drug action), psychiatric illness, and states of consciousness. These studies are instigated at the detailed level involving neurotransmission/receptor activity, bio-chemical processes, and neural circuitry. Neuropsychopharmacology supersedes psychopharmacology in the areas of "how" and "why", and additionally addresses other issues of brain function. Accordingly, the clinical aspect of the field includes psychiatric (psychoactive) as well as neurologic (non-psychoactive) pharmacology-based treatments.
Developments in neuropsychopharmacology may directly impact the studies of anxiety disorders, affective disorders, psychotic disorders, degenerative disorders, eating behavior, and sleep behavior.
The rigorous way fundamental processes of the brain are being discovered is creating a field on par with other “hard sciences” such as chemistry, biology, and physics, so that eventually it may be possible to repair mental illness with ultimate precision. An analogy can be drawn between the brain and an electronic device: neuropsychopharmacology is tantamount to revealing not only the schematic diagram, but the individual components, and every principle of their operation. The bank of amassed detail and complexity involved is huge; mere samples of some of the details are given in this article.
This account hangs on the assumption that materialism, the view that all mental states are reducible to brain states, is true.
This text uses material from Wikipedia, licensed under CC BY-SA
